Travere Therapeutics, Inc. (TVTX)
NASDAQ: TVTX · IEX Real-Time Price · USD
7.71
+0.04 (0.52%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Travere Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2023202220212020201920182017201620152014 2013 - 2012
Revenue
145.24109.46131.84198.32175.34164.25154.94133.5999.8928.2
Upgrade
Revenue Growth (YoY)
32.69%-16.97%-33.52%13.11%6.75%6.01%15.98%33.74%254.19%-
Upgrade
Cost of Revenue
11.454.423.826.135.235.533.614.552.190.57
Upgrade
Gross Profit
133.79105.04128.02192.2170.1158.72151.33129.0497.7127.63
Upgrade
Selling, General & Admin
265.54197.52126.28135.8128.95103.65101.3391.9479.5459.65
Upgrade
Research & Development
244.99227.33201.16131.77140.96123.7678.1770.8250.4347.8
Upgrade
Other Operating Expenses
11.390097.137.5-0.246.236.114.710
Upgrade
Operating Expenses
521.93424.85327.44364.7277.41227.17185.73168.87134.68107.44
Upgrade
Operating Income
-388.14-319.81-199.43-172.51-107.31-68.45-34.4-39.83-36.97-79.81
Upgrade
Interest Expense / Income
11.3311.0119.6819.0518.839.814.424.737.757.44
Upgrade
Other Expense / Income
-288.3-52.66-39.43-2.7720.3123.6119.5413.02-150.1926.16
Upgrade
Pretax Income
-111.18-278.17-179.68-188.79-146.45-101.87-58.36-57.58105.47-113.4
Upgrade
Income Tax
0.220.310.41-19.36-0.020.811.37-9.68-11.77-2.46
Upgrade
Net Income
-111.4-278.48-180.09-169.43-146.43-102.68-59.73-47.9117.24-110.94
Upgrade
Shares Outstanding (Basic)
74646048424039373425
Upgrade
Shares Outstanding (Diluted)
74646048424039383825
Upgrade
Shares Change
16.48%6.56%25.86%12.28%4.72%4.29%1.26%1.88%49.98%76.40%
Upgrade
EPS (Basic)
-1.50-4.37-3.01-3.56-3.46-2.54-1.54-1.293.49-4.43
Upgrade
EPS (Diluted)
-1.50-4.37-3.01-3.56-3.46-2.54-1.54-1.293.17-4.43
Upgrade
Free Cash Flow
-322.28-214.85-38.94-67.31-73.78-44.66-6.61-15.37-8.42-49.81
Upgrade
Free Cash Flow Per Share
-4.34-3.37-0.65-1.42-1.74-1.10-0.17-0.41-0.25-1.99
Upgrade
Gross Margin
92.12%95.96%97.10%96.91%97.01%96.63%97.67%96.59%97.81%97.98%
Upgrade
Operating Margin
-267.24%-292.17%-151.27%-86.98%-61.20%-41.68%-22.20%-29.82%-37.01%-282.98%
Upgrade
Profit Margin
-76.70%-254.41%-136.60%-85.43%-83.51%-62.51%-38.55%-35.86%117.36%-393.36%
Upgrade
Free Cash Flow Margin
-221.90%-196.28%-29.54%-33.94%-42.08%-27.19%-4.26%-11.50%-8.43%-176.63%
Upgrade
Effective Tax Rate
---------11.16%-
Upgrade
EBITDA
-61.31-246.44-147.25-145.16-107.21-72.93-36.14-36.71126.61-100.56
Upgrade
EBITDA Margin
-42.21%-225.14%-111.69%-73.19%-61.15%-44.40%-23.32%-27.48%126.74%-356.56%
Upgrade
Depreciation & Amortization
38.5320.7212.7524.5820.4119.1217.816.1413.395.4
Upgrade
EBIT
-99.84-267.16-160-169.74-127.62-92.06-53.94-52.85113.22-105.96
Upgrade
EBIT Margin
-68.74%-244.07%-121.36%-85.59%-72.79%-56.05%-34.81%-39.56%113.34%-375.72%
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).